COSMOS Pharmaceutical Corporation
Stock Price Chart
2026/03/05 UpdatedPrice Trend
2026/03/05 UpdatedPrice & Trading Details
2026/03/05 UpdatedPRICE
TRADING
Analyst Recommendations 12 analysts
Updated 2026/03/01Shareholder Composition
Updated 2026/03/01Top Mutual Funds / ETFs
Updated 2026/03/01Major Holders
Updated 2026/03/01| Fund Name | Ownership | Shares | Change |
|---|---|---|---|
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
544.1K | +0.42% | |
|
Fidelity Puritan Trust-Fidelity Low-Priced Stock Fund
|
358.7K | 0.00% | |
|
VANGUARD HORIZON FUNDS-Vanguard Global Equity Fund
|
357.7K | +13.02% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
348.1K | +3.02% | |
|
iShares Trust-iShares Core MSCI EAFE ETF
|
272.9K | 0.00% | |
|
iShares Trust-iShares MSCI EAFE Small-Cap ETF
|
148.9K | 0.00% |
| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
Legato Capital Management LLC
|
6.8K | 0.00% |
Dividend History 4Years Growth
Updated 2026/03/01| Year | Dividend | Change |
|---|---|---|
| 2025 | ¥75 | +20.0% |
| 2024 | ¥63 | +6.4% |
| 2023 | ¥59 | +42.4% |
| 2022 | ¥41 | +22.2% |
| 2021 | ¥34 | - |
Financial Performance
2026/03/01 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥755,414M | ¥827,697M | ¥964,989M | ¥1,011,390M |
| Gross Profit | ¥151,447M | ¥168,718M | ¥188,305M | ¥213,281M |
| Operating Income | ¥29,796M | ¥30,129M | ¥31,501M | ¥40,404M |
| Pretax Income | ¥33,100M | ¥32,824M | ¥33,818M | ¥42,626M |
| Net Income | ¥23,155M | ¥23,797M | ¥24,454M | ¥30,978M |
| EPS | ¥292.38 | ¥300.48 | ¥308.61 | - |
| Operating Margin | 3.94% | 3.64% | 3.26% | 3.99% |
| Balance Sheet | ||||
| Total Assets | ¥363,052M | ¥420,967M | ¥476,546M | ¥524,755M |
| Total Equity | ¥190,506M | ¥211,071M | ¥231,440M | ¥257,462M |
| Total Liabilities | ¥172,546M | ¥209,896M | ¥245,106M | ¥267,293M |
| Cash | ¥37,362M | ¥45,928M | ¥52,301M | ¥57,038M |
| Interest-bearing Debt | ¥9,413M | ¥18,201M | ¥34,063M | ¥49,957M |
| Equity Ratio | 52.47% | 50.14% | 48.57% | 49.06% |
| D/E Ratio | 0.05 | 0.09 | 0.15 | 0.19 |
| Cash Flow | ||||
| Operating CF | ¥32,194M | ¥54,434M | ¥55,175M | ¥52,467M |
| Investing CF | -¥43,717M | -¥49,113M | -¥57,329M | -¥55,448M |
| Financing CF | -¥6,222M | ¥3,245M | ¥8,527M | ¥7,717M |
| Free CF | -¥11,303M | ¥7,798M | -¥635M | -¥859M |
| Efficiency | ||||
| ROE | 12.15% | 11.27% | 10.57% | 12.03% |
| ROA | 6.38% | 5.65% | 5.13% | 5.90% |
Latest IR Information
-
Financial Summary for the Second Quarter (Interim Period) of Fiscal Year Ending May 2026 [Japanese GAAP] (Consolidated)
For the second quarter of the fiscal year ending May 2026, consolidated net sales were 537,175 million yen (6.2% increase YoY), operating income was 20,676 million yen (1.6% increase YoY), and net income attributable to owners of parent for the...
Read more -
Notice of Organizational Changes and Personnel Transfers
Effective February 1, 2026, the Legal Department and Hotel Department will be newly established, and the Product Development Department will be integrated into the Product Department. Personnel transfers for directors and department heads will be implemented.
Read more
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥9,132
Rating Score: 2.09 (Based on 12 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
COSMOS Pharmaceutical Corporation engages in the retail sale of pharmaceuticals, cosmetics, daily necessities, and food products in Japan. The company offers general medicines, energy drinks, oral and nursing care products, vitamins, health foods, diet foods, and prescriptions; and hair care and bath products. It also provides baby products, detergents, insect repellents, air fresheners, bath and toilet products, cooking supplies, gardening supplies, household and cleaning supplies, and clothing; processed foods, daily necessities, seasonings, confectionery, beverages, and alcohol; and tobacco and other products. In addition, the company engages in the maintenance and management of buildings and commercial facilities, traffic control, and security contracting activities. It sells its products through retail stores and online. COSMOS Pharmaceutical Corporation was incorporated in 1983 and is headquartered in Fukuoka City, Japan.
